Sanofi, Glaxo to Supply 200 Million Covid Vaccine Doses to Covax

(Bloomberg) -- Sanofi and GlaxoSmithKline Plc said they’ve agreed to make available 200 million doses of the experimental Covid vaccine they’re jointly developing to Covax, a global effort to provi...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.